Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Colorcon
AstraZeneca
Chinese Patent Office
Queensland Health
McKinsey
Boehringer Ingelheim
Dow
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

ALA-CORT Drug Profile

« Back to Dashboard

Which patents cover Ala-cort, and when can generic versions of Ala-cort launch?

Ala-cort is a drug marketed by Crown Labs and is included in two NDAs.

The generic ingredient in ALA-CORT is hydrocortisone. There are sixty-four drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Drug patent expirations by year for ALA-CORT
Pharmacology for ALA-CORT
Medical Subject Heading (MeSH) Categories for ALA-CORT

US Patents and Regulatory Information for ALA-CORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Crown Labs ALA-CORT hydrocortisone CREAM;TOPICAL 080706-007 Jan 5, 2016 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Crown Labs ALA-CORT hydrocortisone CREAM;TOPICAL 080706-006 Approved Prior to Jan 1, 1982 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Crown Labs ALA-CORT hydrocortisone LOTION;TOPICAL 083201-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
AstraZeneca
UBS
Dow
Boehringer Ingelheim
Teva
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot